William S. Rosenstadt
Net Worth

Last updated:

What is William S. Rosenstadt net worth?

The estimated net worth of Mr. William S. Rosenstadt is at least $2,700,001 as of 30 Mar 2017. He owns shares worth $1 as insider and has received compensation worth at least $2,700,000 in Q BioMed Inc..

What is the salary of William S. Rosenstadt?

Mr. William S. Rosenstadt salary is $300,000 per year as Chief Legal Officer, Gen. Counsel & Director in Q BioMed Inc..

How old is William S. Rosenstadt?

Mr. William S. Rosenstadt is 57 years old, born in 1968.

What stocks does William S. Rosenstadt currently own?

As insider, Mr. William S. Rosenstadt owns shares in one company:

Company Title Shares Price per share Total value
Q BioMed Inc. (QBIO) Chief Legal Officer, Gen. Counsel & Director 975,549 $0 $1

What does Q BioMed Inc. do?

Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B for liver cancer. Q BioMed Inc. has a partnership with Mannin Research Inc. for the development of therapeutics to treat acute respiratory distress syndrome, glaucoma, kidney diseases, and others. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was incorporated in 2013 and is based in New York, New York.

QBIO logo
QBIO
Q BioMed Inc.
$0

William S. Rosenstadt insider trading

Q BioMed Inc.

Mr. William S. Rosenstadt has made 36 insider trades between 2016-2017, according to the Form 4 filled with the SEC. Most recently he sold 5,000 units of QBIO stock on 30 Mar 2017.

The largest trade he's ever made was exercising 50,000 units of QBIO stock on 15 Jul 2016. As of 30 Mar 2017 he still owns at least 975,549 units of QBIO stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 4,400 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 3,700 N/A N/A
Sale
Common Stock 3,700 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 2,200 N/A N/A
Sale
Common Stock 2,200 N/A N/A
Sale
Common Stock 1,900 N/A N/A
Sale
Common Stock 1,900 N/A N/A
Sale
Common Stock 100 N/A N/A
Sale
Common Stock 100 N/A N/A
Sale
Common Stock 1,200 N/A N/A
Sale
Common Stock 1,200 N/A N/A
Sale
Common Stock 3,800 N/A N/A
Sale
Common Stock 3,800 N/A N/A
Sale
Common Stock 900 N/A N/A
Sale
Common Stock 900 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 1,800 N/A N/A
Sale
Common Stock 1,800 N/A N/A
Sale
Common Stock 1,000 N/A N/A
Sale
Common Stock 1,000 N/A N/A
Sale
Common Stock 4,651 N/A N/A
Sale
Common Stock 4,651 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 3,800 N/A N/A
Sale
Common Stock 3,800 N/A N/A
Purchase
Warrant 50,000 N/A N/A

Q BioMed key executives

Q BioMed Inc. executives and other stock owners filed with the SEC:

  • Mr. Denis D. Corin (52) Chairman, Chief Executive Officer, Chief Financial Officer, Pres and Acting Principal Financial & Accounting Officer
  • Mr. William S. Rosenstadt (57) Chief Legal Officer, Gen. Counsel & Director
  • Ms. Kristin Marvin Keller (49) Chief Commercial Officer